The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis
OBJECTIVE: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, requires consistent high-quality care to reduce variation in patient experience and improve outcomes. The IBD Standards previously published in 2009, 2013 and 2019 have provided an aspirational framework for best practice. Since 2019, two rounds of national benchmarking with patient engagement, healthcare professional (HCP) consultation and new evidence have highlighted areas for quality improvement (QI). We aimed to develop the 2026 IBD UK Standards of healthcare for adults and children, ensuring they reflect current and aspirational best practice and to support future QI initiatives. METHODS: A multidisciplinary working group of 18 HCPs and 4 people with lived experience assessed the 59 IBD standards from 2019, categorising them as needing no change, minor or major amendment or deletion. New standards were developed through iterative drafting and consensus review, with feedback incorporated from 47 external HCPs and a patient workshop. The 2026 standards remain aspirational, structured across seven domains: the IBD service, pre-diagnosis, newly diagnosed, flare management, surgery, inpatient care and ongoing care. RESULTS: The 2026 IBD UK Standards comprise 60 statements: 6 unchanged from 2019, 48 updated, 7 deleted and 6 new. Key themes include multidisciplinary, coordinated care with defined leadership; age-appropriate transition pathways; timely referral from primary care, access to diagnostic tests, treatments and surgery; patient-centred care, including better communication, personalised care plans, shared decision-making and support for self-management; holistic assessment and management of physical, nutritional and psychological need; QI and audit supported by electronic systems; research participation and innovation. CONCLUSIONS: The 2026 IBD UK Standards provide a contemporary aspirational framework to drive consistent, high-quality, personalised care across the UK. They aim to reduce inequality, improve experience and outcomes through support for patient-centred shared decision-making, national benchmarking, service development, patient involvement and QI.
Authors
- Pearl Avery (ORCID: https://orcid.org/0000-0003-2156-7893)
- Graham Bell (ORCID: https://orcid.org/0000-0003-4604-6410)
- K Keetarut (ORCID: https://orcid.org/0000-0002-7835-4613)
- Caroline Brocklehurst
- Valerio Celentano (ORCID: https://orcid.org/0000-0002-3562-9082)
- Rachel Dodd
- Gayle Martin (ORCID: https://orcid.org/0009-0005-2000-5612)
- Clare Tibbatts
- Rafeeq Muhammed (ORCID: https://orcid.org/0000-0001-6107-8109)
- Fiona Rees (ORCID: https://orcid.org/0009-0003-7637-1166)
- Lisa Younge (ORCID: https://orcid.org/0000-0002-3436-9696)
- Nathaniel Woo
- Ruth Rudling
- J Turner
- G Bhatnagar
- Marianne Radcliffe
- A Barney Hawthorne
- Catherine Winsor
- Amy Gittins
- Sarah Bayliss
- Christopher A Lamb
- Christian P Selinger
- Debra Attwood
- Ian Arnott
- Vicky Buckley
- IBD UK Board
Institutions
- Barking, Havering And Redbridge University Hospitals NHS Trust (GB)
- Cardiff and Vale University Health Board (GB)
- University of Leeds (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- University of Liverpool (GB)
- British Dietetic Association (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Western General Hospital (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Aneurin Bevan University Health Board (GB)
- Gloucestershire Hospitals NHS Foundation Trust (GB)
- Frimley Health NHS Foundation Trust (GB)
- Crohn's and Colitis UK (GB)
- University Hospitals Sussex NHS Foundation Trust (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Mid Yorkshire Hospitals NHS Trust (GB)
- St Mark's Hospital (GB)
- South Eastern Health and Social Care Trust (GB)
- University College London (GB)
- Imperial College London (GB)
- Morehouse School of Medicine (US)
- Newcastle University (GB)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-002227
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Biogen
- Leona M. and Harry B. Helmsley Charitable Trust
- Wellcome Trust
- European Bioinformatics Institute
- National Institute for Health and Care Research
- Crohn's and Colitis UK
- Innovative Medicines Initiative
- Tillotts Pharma
- Nordic Pharma Group
- Genentech
- NIHR BioResource
- Medical Research Council
- NIHR Newcastle Biomedical Research Centre